Free shipping on all orders over $ 500

Delpazolid

Cat. No. M6239

All AbMole products are for research use only, cannot be used for human consumption.

Delpazolid Structure
Synonym:

LCB01-0371

Size Price Availability Quantity
1mg USD 50 In stock
5mg USD 85 In stock
10mg USD 130 In stock
25mg USD 260 In stock
50mg USD 400 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

In vitro: Delpazolid (LCB01-0371), at concentrations of 1×MIC and 2×MIC, has bacteriostatic activity against MSSA and MRSA after 24 h. At concentrations of 4×MIC and 8×MIC, Delpazolid shows bacteriostatic activity, but there is no regrowth at concentrations of 4×MIC and 8×MIC after 24 h of incubation. The survival of M. abscessus is greatly decreased in the presence of Delpazolid (LCB-0371) (MIC50=1.2 μg/mL). Delpazolid dramatically decreases the number of intracellular mycobacteria present at 2 days after infection at concentrations of 0.1, 1, and 10 μg/mL.

In vivo: When administered orally, Delpazolid (LCB01-0371) shows potent protective effects against systemic infections caused by Gram-positive and Gram-negative bacteria. Against infection caused by S. aureus Giorgio (MSSA), the ED50 of Delpazolid is 4.53 mg/kg of body weight. Against S. aureus p125 (MRSA), the ED50 of Delpazolid is 2.96 mg/kg. When Delpazolid (LCB-0371) is administered at 100 mg/kg daily (by gavage), the colony-forming unit (CFU) counts tend to be decreased in the lungs of mice at 7 days after infection.

Protocol (for reference only)
Cell Experiment
Cell lines
Preparation method
Concentrations
Incubation time 2 days
Animal Experiment
Animal models WT mice
Formulation PBS
Dosages 2.96 mg/kg
Administration oral
Chemical Information
Molecular Weight 308.31
Formula C14H17FN4O3
CAS Number 1219707-39-7
Form Solid
Solubility (25°C) 30 mg/mL in DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Kim TS, et al. Antimicrob Agents Chemother. Activity of LCB01-0371, a Novel Oxazolidinone, against Mycobacterium abscessus.

[2] Jeong JW, et al. Antimicrob Agents Chemother. In vitro and in vivo activities of LCB01-0371, a new oxazolidinone.

Related Antibiotic Products
Kanamycin sulfate

Kanamycin sulfate is an aminoglycoside antibiotic that acts as a bacteriostatic agent by binding to the bacterial 30S ribosome.

Marbofloxacin

Marbofloxacin is a potent antibiotic of the 3rd generation fluoroquinolone group which inhibiting bacterial DNA replication.

Linezolid

Linezolid (PNU-100766) is a synthetic antibiotic. Linezolid acts by inhibiting the initiation of bacterial protein synthesis.

Daptomycin

Daptomycin is the first member of a new class of bactericidal antibiotics, the cyclic lipopeptides.

Sulfadimethoxine

Sulfadimethoxine (trade name Di-Methox, Albon) is a sulfonamide antibiotic.

  Catalog
Abmole Inhibitor Catalog




Keywords: Delpazolid, LCB01-0371 supplier, Antibiotic, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.